Ironically, Ebola was one indication for ST-246/247 that the company felt could be developed via their pipeline.
They may have even started preliminary studies on the feasibility of pursuing it. Maybe even received some modest grant money to pursue it. Then...nothing.
Not only would that had been a big money maker today given the outbreak and spread of Ebola in Africa,
but the PR and goodwill for the company would have been worth it's weight in gold. To dream the dreams of what could have been if only, etc. etc. ... What a shame.